F145-0541 Screening compound: N~1~-(1-benzyl-4-piperidyl)-3-(4-oxo-3,5,6,7,8,9-hexahydro-4H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-2-yl)propanamide

F145-0541 Screening compound: N~1~-(1-benzyl-4-piperidyl)-3-(4-oxo-3,5,6,7,8,9-hexahydro-4H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-2-yl)propanamide
F145-0541 Screening compound: N~1~-(1-benzyl-4-piperidyl)-3-(4-oxo-3,5,6,7,8,9-hexahydro-4H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-2-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F145-0541
N~1~-(1-benzyl-4-piperidyl)-3-(4-oxo-3,5,6,7,8,9-hexahydro-4H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-2-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F145-0541

Molecular Formula

C26H32N4O2S (C26 H32 N4 O2 S)

Compound Name

N~1~-(1-benzyl-4-piperidyl)-3-(4-oxo-3,5,6,7,8,9-hexahydro-4H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-2-yl)propanamide

IUPAC name

N-(1-benzylpiperidin-4-yl)-3-{3-oxo-8-thia-46-diazatricyclo[7.5.0.0^{27}]tetradeca-1(9)2(7)5-trien-5-yl}propanamide

SMILES

O=C(CCC(N1)=Nc(sc2c3CCCCC2)c3C1=O)NC1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C26H32N4O2S/c31-23(27-19-13-15-30(16-14-19)17-18-7-3-1-4-8-18)12-11-22-28-25(32)24-20-9-5-2-6-10-21(20)33-26(24)29-22/h1,3-4,7-8,19H,2,5-6,9-17H2,(H,27,31)(H,28,29,32)

InChI Key

CEGYLAWBOXPJOT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD11998507

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.63

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.650

Distribution Coefficient, logD

2.092

Water Solubility, LogSw

-4.26

Polar Surface Area

62.792

Acid Dissociation Constant (pKa)

10.25

Base Dissociation Constant (pKb)

8.95

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

F145-0541 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F145-0541 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F145-0541?
Check Price and Availability of F145-0541, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F145-0541 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F145-0541
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F145-0541
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F145-0541 available by request